Comments
Torrent Pharmaceuticals Limited on Tuesday posted standalone net profit of ₹223 crore for the quarter ended June 2019, up from ₹122 crore reported in the same quarter last year, showing a growth of about 83 per cent on year-on-year basis.
Standalone income from operations stood at ₹1,603 crore for the quarter under review, up from ₹1,452 crore reported in the same quarter last year.
On consolidated basis, company's net profit for the quarter stood at ₹216 crore, up 33 per cent from ₹163 crore reported in the corresponding quarter last year.
Total consolidated income from operations stood at ₹2,022 crore, up from ₹1,872 crore.
Company's India business grew by 9 per cent to ₹907 crore for the quarter. Base impact of discontinued products in previous year is 2 per cent. Adjusted for this growth is 11 per cent. The US revenues stood at ₹376 crore, up by 13 per cent on year-on-year basis.
Consolidated EBITDA stood at ₹558 crores with EBITDA margin of 28 per cent, up by 11 per cent on year on year basis, the company informed in a statement.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.